Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 23.135E | Other Identifier | Aurora IRB |
Not provided
Not provided
Not provided
Principal Investigator left Advocate Health
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to demonstrate the treatment outcomes of patients with chronic knee pain secondary to osteoarthritis that have received a temporary peripheral nerve stimulation system.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients treated with a temporary PNS system | These patients will receive a temporary PNS system for their knee pain secondary to osteoarthritis |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Temporary PNS system | Device | This system remains in place up to 60 days, then removed. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Average change from baseline to end of treatment in average pain intensity measured through BPI-SF item 5. | up to 60 days post lead placement |
| Measure | Description | Time Frame |
|---|---|---|
| Average change from baseline to end of treatment in health-related quality of life measured through PROMIS-29. | up to 60 days post lead placement | |
| Average change from baseline to end of treatment in pain interference measured through BPI-SF. | up to 60 days post lead placement |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Study population includes patients with chronic knee pain secondary to osteoarthritis of the knee and will receive a temporary peripheral nerve stimulation device.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Littlefield Lauren, MD | Aurora Medical Center Oshkosh - 855 N Westhaven Dr | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aurora Health Center | Fond du Lac | Wisconsin | 54937 | United States | ||
| Aurora Health Oshkosh |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020370 | Osteoarthritis, Knee |
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Average change in chronic pain related medication intake at end of treatment compared to baseline in Morphine Miligram Equivalents (MME) | up to 60 days post lead placement |
| Overall patient global impression of change (PGIC) at end of treatment. | up to 60 days post lead placement |
| Overall incidence of lead migration/fracture at the end of treatment. | up to 60 days post lead placement |
| Average change from baseline to 7- and 30-days post-implant; and 6- and 12-months post-explant in average pain intensity measured through BPI-SF item 5. | 7 and 30 days post lead placement; and 6 and 12 month post lead pull |
| Average change from baseline to 6- and 12-months post-explant in health-related quality of life measured through PROMIS-29. | 7 and 30 days post lead placement; and 6 and 12 month post lead pull |
| Average change from baseline to 6- and 12-months post-explant in pain interference measured through BPI-SF. | 7 and 30 days post lead placement; and 6 and 12 month post lead pull |
| Overall patient global impression of change (PGIC) at 6 months and end of study. | 6 and 12 months post lead pull |
| Overall incidence of lead migration/fracture during the study. | 12 months |
| Oshkosh |
| Wisconsin |
| 54914 |
| United States |